March 21, 2023
RFA-CA-23-025 - Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)
National Cancer Institute (NCI)
The purpose of this Notice is to change the Application Due date for RFA-CA-23-025 "Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required)".
Part 1. Overview Information, Key Dates
Currently, it reads:
Open Date (Earliest Submission Date): May 30, 2023
Letter of Intent Due Date(s): 30 days prior to application due date.
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| June 30, 2023 | Not Applicable | Not Applicable | October 2023 | January 2024 | April 2024 |
Expiration Date: July 1, 2023
Revised to read (in bold italics):
Open Date (Earliest Submission Date): June 24, 2023
Letter of Intent Due Date(s): 30 days prior to application due date.
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| July 24, 2023 | Not Applicable | Not Applicable | October 2023 | January 2024 | April 2024 |
Expiration Date: July 25, 2023
All other aspects of RFA-CA-23-025 remain unchanged.
Scientific/Research Contact(s)
Michelle Mollica, PhD, MPH, RN, OCN
National Cancer Institute (NCI)
Telephone: 240-276-7621
Email: [email protected]
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]
Financial/Grants Management Contact(s)
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 301-496-8634
Email: [email protected]
and Human Services (HHS)
